1. Academic Validation
  2. Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice

Obesity and mild hyperinsulinemia found in neuropeptide Y-Y1 receptor-deficient mice

  • Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15659-64. doi: 10.1073/pnas.95.26.15659.
A Kushi 1 H Sasai H Koizumi N Takeda M Yokoyama M Nakamura
Affiliations

Affiliation

  • 1 Central Pharmaceutical Research Institute, Pharmaceutical Frontiers Research Laboratory, Japan Tobacco Inc., 1-13-2, Fukuura, Kanazawa-ku, Yokohama, Kanagawa 236, Japan.
Abstract

To elucidate the role of neuropeptide Y (NPY)-Y1 receptor (Y1-R) in food intake, energy expenditure, and Other possible functions, we have generated Y1-R-deficient mice (Y1-R-/-) by gene targeting. Contrary to our hypothesis that the lack of NPY signaling via Y1-R would result in impaired feeding and weight loss, Y1-R-/- mice showed a moderate obesity and mild hyperinsulinemia without hyperphagia. Although there was some variation between males and females, typical characteristics of Y1-R-/- mice include: greater body weight (females more than males), an increase in the weight of white adipose tissue (WAT) (approximately 4-fold in females), an elevated basal level of plasma Insulin (approximately 2-fold), impaired Insulin secretion in response to glucose administration, and a significant changes in mitochondrial uncoupling protein (UCP) gene expression (up-regulation of UCP1 in brown adipose tissue and down-regulation of UCP2 in WAT). These results suggest either that the Y1-R in the hypothalamus is not a key molecule in the Leptin/NPY pathway, which controls feeding behavior, or that its deficiency is compensated by Other receptors, such as NPY-Y5 receptor. We believe that the mild obesity found in Y1-R-/- mice (especially females) was caused by the impaired control of Insulin secretion and/or low energy expenditure, including the lowered expression of UCP2 in WAT. This model will be useful for studying the mechanism of mild obesity and abnormal Insulin metabolism in noninsulin-dependent diabetes mellitus.

Figures